옵션 체인은 다양한 행사가격과 만기일에 대한 Nukkleus의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Nukkleus에 대한 시장 심리를 평가합니다..

Nukkleus (NASDAQ:NUKK) 주식, 옵션 체인

Nukkleus

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically, the majority of its revenue is generated from the United Kingdom and the rest from the United States and Malta.

Equities

News

Markets

NUKK

QUBT

TEVA

TSLA

화요일(17일) 미국 증시는 11월 소매판매 발표 이후 주요 지수가  하락했다. 소매판매 데이터는 연준의 내년 금리인하 지연 가능성에 대한 우려를 불러일으켰다. 뉴클러스, 마이크론, 테바 파마슈티컬, 퀀텀 컴퓨팅 및 테슬라

화요일 주목받은 주식: 뉴클러스, 마이크론, 테바 파마슈티컬, 퀀텀 컴퓨팅 및 테슬라

Nukkleus Inc

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Silence Therapeutics PLC &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>)</h3>
<ul>
<li>On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a <a href="https://www.benzinga.com/quote/SLN">52-week low of $5.81</a>.</li>
<li>RSI Value: 26.72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"> latest SLN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="901" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png" alt="" class="wp-image-697338" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png 901w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-768x713.png 768w" sizes="(max-width: 901px) 100vw, 901px" /></a></figure>
<h3 class="wp-block-heading">ModivCare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Nov. 6, ModivCare posted weaker-than-expected quarterly results. &#8220;This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment,&#8221; stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and <a href="https://www.benzinga.com/quote/MODV">has a 52-week low</a> of $11.00.</li>
<li>RSI Value: 28.52</li>
<li>MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">trend in MODV stock.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="915" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png" alt="" class="wp-image-697341" style="width:603px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-768x705.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Olema Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>)</h3>
<ul>
<li>On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/OLMA">low of $6.08</a>.</li>
<li>RSI Value: 23.69</li>
<li>OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">breakout in OLMA shares.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png" alt="" class="wp-image-697342" style="width:639px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-768x720.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42531171/top-2-utilities-stocks-that-could-sink-your-portfolio-this-quarter">Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Trading Ideas

MODV

OLMA

Top 3 Health Care Stocks That May Explode In Q4

Earnings

Earnings Beats

Jabil Q1 2025 Adj. EPS $2.00 Beats $1.88 Estimate, Sales $6.994B Beat $6.608B Estimate

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications

ARAY

Accuray's CyberKnife System Offers Promising Outcomes For Brainstem Metastases, Highlighting Safety And Precision

Northland Capital Markets analyst Bobby Brooks maintains Excelerate Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) with a Outperform and raises the price target from $29 to $37.

Price Target

Analyst Ratings

Northland Capital Markets Maintains Outperform on Excelerate Energy, Raises Price Target to $37

Salesforce&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) targets employing 2,000 people in the form of sales reps, marketers, and customer service agents to sell <a target="_blank" href="https://www.benzinga.com/topic/ai" rel="noreferrer noopener">artificial intelligence</a> software to clients, CNBC <a target="_blank" href="https://www.cnbc.com/2024/12/17/salesforce-will-hire-2000-people-to-sell-ai-products-benioff-says.html" rel="noreferrer noopener">cited</a> CEO Marc Benioff at a company event in San Francisco on Tuesday.
In November, Benioff shared plans to employ 1,000 salespeople focusing on AI. Benioff told CNBC Salesforce already had 9,000 referrals for the 2,000 positions.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/12/42536593/verizon-teams-up-with-nvidia-to-power-ai-apps-over-private-5g-networks" rel="noreferrer noopener">Verizon Teams Up With Nvidia To Power AI Apps Over Private 5G Networks</a>
On Tuesday, Salesforce announced that a second generation&nbsp;of its Agentforce technology, capable of tackling questions in Salesforce's Slack communications app, will be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42537776/introducing-agentforce-2-0-the-digital-labor-platform-for-building-a-limitless-workforce" rel="noreferrer noopener">available in February 2025</a>.
Salesforce has embedded experimental AI agents on its homepage to enhance user interaction. It manages 32,000 weekly queries through its chat-based help page, with only 5,000 requiring human escalation, down from 10,000.
Benioff highlighted these advancements as evidence of AI's growing role in improving customer support efficiency.
Benioff contrasted Salesforce's offerings with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), noting the limited visibility of its Copilot-branded AI tools. Microsoft countered, stating that its AI solutions are driving measurable improvements, including a 9.4% boost in revenue per seller and an 11.5% reduction in case resolution time.
Salesforce's hiring spree comes nearly two years after the company laid off over 7,000 employees to adjust to economic conditions.
On Tuesday, Salesforce and Adecco Group boosted recruiting with Agentforce and Data Cloud for <a target="_blank" href="https://www.benzinga.com/news/contracts/24/12/42532242/salesforce-supercharges-adecco-vivint-with-ai-details" rel="noreferrer noopener">faster candidate matching</a>. Vivint, a provider of smart home and security solutions, tapped Agentforce to enhance its customer service&nbsp;teams with 24/7 autonomous agent support.
On TechCrunch's Equity podcast, Benioff <a target="_blank" href="https://techcrunch.com/2024/12/17/salesforce-plans-to-hire-2000-people-to-sell-its-ai-products/" rel="noreferrer noopener">predicted</a> that Salesforce will surpass a billion agents within the next 12 months. In October, Northland Capital Partners <a target="_blank" href="https://www.benzinga.com/top-stories/24/10/41145130/salesforces-genai-platform-agentforce-on-par-with-microsoft-analyst" rel="noreferrer noopener">stated that the</a> AgentForce platform now matches Microsoft's capabilities.
Salesforce&nbsp;stock surged over 37% year-to-date.
Salesforce reported <a target="_blank" href="https://www.benzinga.com/news/earnings/24/12/42302924/salesforce-q3-earnings-revenue-beat-eps-miss-free-cash-flow-up-30-ai-driving-groundbreaking-transformation-and-more" rel="noreferrer noopener">a third-quarter revenue</a> of $9.44 billion, up 8%, above the&nbsp;analyst consensus of $9.35 billion. The adjusted EPS of $2.41 missed the analyst consensus of $2.44.
Salesforce expects fourth-quarter revenue of $9.9 billion-$10.1 billion versus $10.04 billion analyst consensus. It anticipates fourth-quarter adjusted EPS of $2.57-$2.62 compared to consensus estimate of $2.61.&nbsp;
Investors can gain exposure to Salesforce through JPMorgan Equity Premium Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEPI#NYSE">JEPI</a>) and SPDR Series Trust SPDR Portfolio S&amp;P 500 Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPYG#NYSE">SPYG</a>).
Price Action: CRM stock traded higher by 0.71% to $353.47 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42536024/taiwan-eyes-amazons-kuiper-as-starlink-faces-hurdles" target="_blank" rel="noreferrer noopener">Amazon's Project Kuiper In Talks With Taiwan For Satellite Partnership</a></li>
</ul>
Photo via Shutterstock

Tech

Media

JEPI

MSFT

SPYG

Salesforce Doubles AI Hiring Goal, To Add 2K Sales Roles

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares are experiencing a rise in premarket trading on Wednesday, as the company officially gears up for the launch of its new sub-brand, Firefly, which <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">is set to be unveiled this weekend.</a>
The Firefly brand, focused on premium smart electric vehicles for global urban consumers, made a significant step forward today with the launch of its official WeChat account, mini-program, and mobile app, <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-warming-up-firefly-logo-app/" rel="noreferrer noopener">reports</a> CnEV Post.
The brand also revealed its logo for the first time.
Firefly draws inspiration from the firefly insect, known for its glowing, self-illuminating nature. The brand describes itself as small, agile, energetic, and dynamic, targeting a younger, urban audience.
In addition to Firefly&#8217;s preparations, NIO also shared six new images of its ET9 sedan on Weibo, featuring a sleek blue exterior and highlighting several design details, CnEV Post <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-new-images-et9/" rel="noreferrer noopener">writes</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/previews/24/12/42549182/us-stocks-to-open-higher-as-rate-cut-expectations-surge-all-eyes-on-dow-jones-to-break-its-9-day-losing-streak" rel="noreferrer noopener">US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak</a>
This comes just before Nio Day 2024, which will take place this Saturday in Guangzhou, Guangdong province. The event will spotlight the Firefly sub-brand and its debut model, along with the official launch of the Nio ET9.
The Nio ET9, which was first revealed at Nio Day 2023, carries a pre-sale price of RMB 800,000, making it the most expensive vehicle in Nio&#8217;s lineup.
Deliveries are expected to begin in the first quarter of 2025, marking a key expansion of Nio&#8217;s product range to appeal to a broader market.
Price Action: NIO shares are trading higher by 1.10% to $4.59 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024" target="_blank" rel="noreferrer noopener">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Movers

Personal Finance

General

What's Going On With NIO Stock Today?

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) continues to trend downward, reflecting broader stagnation in <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42545419/bitcoin-ethereum-dogecoin-stay-muted-before-feds-interest-rate-decision-analyst-says-btc-in-parabolic-phase-reveals-its-duration">the cryptocurrency market</a>.   
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3885</td>
<td>$57.2 billion</td>
<td>-4.1%</td>
<td>-3.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002602</td>
<td>$15.3 billion</td>
<td>-4.7%</td>
<td>-5.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00002179</td>
<td>$9.2 billion</td>
<td>-7.2%</td>
<td>-8.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader More Crypto Online notes that Dogecoin&#8217;s recent 4% drop means the price stuck in a consolidation phase. 
He <a href="https://x.com/Morecryptoonl/status/1869217158040879159">suggests</a> that holding above $0.365 could open the door for an upside breakout, but a drop below this level might direct attention to the $0.25–$0.337 support zone.
Crypto chart analyst Ali Martinez highlights negative market sentiment surrounding Dogecoin, attributing the current price stagnation to trader impatience during this extended consolidation period.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Market sentiment for <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has turned negative. It seems as if traders are getting impatient during the ongoing price consolidation! <a href="https://t.co/yb29147Bvg">pic.twitter.com/yb29147Bvg</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1869119123919183935?ref_src=twsrc%5Etfw">December 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin <a href="https://x.com/Kev_Capital_TA/status/1869159630045081778">adds</a> that Dogecoin continues to face resistance, failing to reclaim the Macro .786 Fib level for over a week and losing support at the Macro .5 Fib on the linear chart. 
He also points out bearish signals for Bitcoin, which faces rejection at its Macro 1.703 Fib level, alongside substantial downside liquidity risks.
Kevin believes the market&#8217;s short-term outlook leans bearish, given the Federal Reserve&#8217;s potential rate pause and the Bank of Japan&#8217;s anticipated rate hike.
Statistics: According to Coinglass, Dogecoin short liquidations have dropped to $629,800, the lowest level since Oct. 13.
Additionally, spot trading data shows continuous negative net flows since Dec. 12, with a net outflow of $34.3 million as of Dec.18.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42488734/dogecoin-price-stuck-around-40-cents-why-isnt-doge-moving">Dogecoin Price Stuck Around 40 Cents: Why Isn&#8217;t DOGE Moving?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin Down Another 4% As Sentiment Sours: What Is Going On?

JP Morgan analyst Doug Anmuth maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and raises the price target from $212 to $232.

GOOGL

JP Morgan Maintains Overweight on Alphabet, Raises Price Target to $232

JMP Securities analyst Aaron Kimson initiates coverage on Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Market Outperform rating and announces Price Target of $7.

Initiation

BLND

JMP Securities Initiates Coverage On Blend Labs with Market Outperform Rating, Announces Price Target of $7

Northland Capital Markets analyst Tim Savageaux reiterates Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) with a Outperform and raises the price target from $25 to $40.

Reiteration

AAOI

Northland Capital Markets Reiterates Outperform on Applied Optoelectronics, Raises Price Target to $40

Keybanc analyst Alex Markgraff upgrades BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) from Sector Weight to Overweight and announces $115 price target.

Upgrades

BILL

Keybanc Upgrades BILL Holdings to Overweight, Announces $115 Price Target

Northland Capital Markets analyst Michael Latimore initiates coverage on Rezolve AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) with a Outperform rating and announces Price Target of $5.

RZLV

Northland Capital Markets Initiates Coverage On Rezolve AI with Outperform Rating, Announces Price Target of $5

Global fund managers are shrinking their cash holdings and investing heavily in U.S. stocks, pushing a key indicator to a level that Bank of America believes could signal an impending sell-off in global equities.
What Happened: The Bank of America&#8217;s survey of global fund managers has been showing a &#8220;super-bullish sentiment, with record low allocation to cash, record-high allocation to U.S. stocks and three-year high global risk appetite driven by &#8216;Trump 2.0&#8217; growth optimism and a compliant rate cut by Fed.&#8221;
Cash as a percentage of total assets under management dropped to 3.9% in December. The only time fund managers&#8217; cash allocations were near the current levels was during January to March in 2002 and in February 2011.
According to the BofA survey, a 3.9% cash allocation triggers a &#8220;sell signal,&#8221; as the allocation to the U.S. equities advanced to a record high of net 36% overweight.
See Also: <a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a>
Why It Matters: This year, investors have flocked to U.S. stocks, anticipating that the America First policies proposed by President-elect Donald Trump will enhance domestic corporate earnings.
Morgan Stanley <a href="https://www.benzinga.com/markets/equities/24/12/42382786/morgan-stanley-narrows-down-winning-and-losing-bets-in-the-first-100-days-of-trump-administration">highlighted</a> certain headwinds to the positive developments expected by a majority of analysts and fund managers.
&#8220;Slower-than-expected deregulation and shallower tax cuts could impact the markets,&#8221; it said in a 2025 outlook.
&#8220;Investors should remain vigilant as tech valuations climb further, with an eye toward rebalancing opportunities early next year,&#8221; said Jeremy Siegel, a senior economist at WisdomTree and emeritus professor of finance at the University of Pennsylvania.
The BofA survey further notes that investors have been long &#8216;Magnificent Seven&#8217; stocks, seeing crowded trades for the 21st consecutive month.
Also, the allocation to emerging market equities fell by 23% points month-on-month in December, which was the lowest exposure to this sector since September 2024, before China announced its stimulus measures.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42546991/dows-rare-nine-day-decline-falls-behind-267-single-day-crashes-since-1900">Dow&#8217;s Rare Nine-Day Decline Falls Behind 267 Single-Day Crashes Since 1900: Is Tech Shift To Blame?</a></li>
</ul>
Photo courtesy: Unsplash

Analyst Color

Cash Holdings Of Asset Managers Lowest In 13 Years, Says BofA, Flagging 'Sell' Signal Amid 'Trump 2.0 Optimism'

CRGO

Freightos And Swiss WorldCargo Partner To Revolutionize Digital Air Cargo Booking Across Global Markets

Keybanc analyst Arvind Ramnani upgrades Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) from Sector Weight to Overweight and announces $126 price target.

QTWO

Keybanc Upgrades Q2 Holdings to Overweight, Announces $126 Price Target

Key preclinical milestone for novel, non-opioid extended-release pain therapeutic&nbsp;&nbsp;

SILO

Silo Pharma Launches Pharmacokinetic Study For SP-26, Targeting Non-Opioid Chronic Pain Treatment

AMST

Amesite Disclosed Nursemagic Enterprise Contract Wins In High Growth Companies With Hundreds Of Franchise Owners Across The Country

AGEN

Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

TKLF

CORRECTION: Tokyo Lifestyle Co H1 EPS $0.03 Down From $0.05 YoY, Sales $98.00M Up From $74.16M YoY

Draganfly's medical drone delivery infrastructure offers new model for future improvement in service time for Home Hospital care

DPRO

Draganfly Successfully Conducts Proof-Of-Concept Flights For Medical Drone Delivery With Mass General Brigham

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we break down all of the biggest news sending shares higher and lower on Tuesday!



Moving stocks this morning are a bankruptcy filing, earnings reports, new deals and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssep-stock-quote/">CSSEP</a>) stock is rocketing more than 222% after <a href="https://investorplace.com/2024/07/why-is-chicken-soup-for-the-soul-entertainment-csse-stock-down-29-today/">falling yesterday on a bankruptcy filing</a>. </li>



<li>Chicken Soup for the Soul Entertainment, Inc. &ndash; 9.50% Notes due 2025 (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssen-stock-quote/">CSSEN</a>) are soaring close to 82% after yesterday&rsquo;s drop.</li>



<li>Roadzen (NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/">RDZN</a>) shares are surging over 60% alongside its <a href="https://www.stocktitan.net/news/RDZN/roadzen-reports-record-revenue-growth-in-its-first-fiscal-year-as-a-47jyl3yay9h1.html">first public year-end earnings</a>.</li>



<li>IMAC (NASDAQ:<a href="https://investorplace.com/stock-quotes/back-stock-quote/">BACK</a>) stock is gaining more than 37% without any clear news this morning.</li>



<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are rising over 31% after <a href="https://www.marketwatch.com/story/versus-systems-shares-climb-on-interim-ceo-appointment-business-review-589cd51b">naming an interim CEO</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is increasing 30% despite a lack of news this morning.</li>



<li>Chicken Soup for the Soul (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are climbing more than 19% with its bankruptcy filing.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) stock is heading over 16% higher alongside heavy pre-market trading.</li>



<li>US Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/useg-stock-quote/">USEG</a>) shares are jumping more than 14% <a href="https://www.nasdaq.com/press-release/us-energy-corp-announces-transformative-acquisition-targeting-helium-production-2024">on a new acquisition deal</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) stock is up over 14% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) stock is plummeting nearly 35% despite a lack of news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are diving almost 15% without any apparent news today.</li>



<li>Applied DNA Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apdn-stock-quote/">APDN</a>) stock is tumbling close to 12% without any news to note.</li>



<li>Senti Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/snti-stock-quote/">SNTI</a>) shares are taking a more than 11% beating <a href="https://ca.investing.com/news/company-news/senti-biosciences-awarded-8-million-for-cancer-trial-93CH-3480501">after a cancer funding rally yesterday</a>.</li>



<li>Datasea (NASDAQ:<a href="https://investorplace.com/stock-quotes/dtss-stock-quote/">DTSS</a>) stock is sliding close to 11% after <a href="https://www.marketwatch.com/story/datasea-shares-up-20-on-three-sales-agreements-for-china-units-de49a130">rallying yesterday on sales agreements</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are falling over 10% despite a lack of news this morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is decreasing more than 10% without any news to report.</li>



<li>Hudson Pacific Properties (NYSE:<a href="https://investorplace.com/stock-quotes/hpp-stock-quote/">HPP</a>) shares are dropping over 10% despite a lack of relevant news today.</li>



<li>Vintage Wine Estates (NASDAQ:<a href="https://investorplace.com/stock-quotes/vwe-stock-quote/">VWE</a>) stock is slipping more than 10% this morning.</li>



<li>Akso Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/ahg-stock-quote/">AHG</a>) shares close out our pre-market stock movers down over 10% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!



Moving stocks this morning are earnings reports, a settlement agreement, the pricing of a public offering and more.



Let&rsquo;s get into that below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is rocketing close to 254% alongside heavy pre-market trading.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are soaring more than 122% with strong early morning trading.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is surging nearly 78% with heavy early morning trading today.</li>



<li>Frequency Electronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/feim-stock-quote/">FEIM</a>) shares are rising almost 33% alongside its <a href="https://www.marketwatch.com/story/frequency-electronics-shares-climb-on-higher-4q-earnings-a32189da">Q4 earnings report</a>.</li>



<li>Mammoth Energy Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/tusk-stock-quote/">TUSK</a>) stock is heading over 29% higher after <a href="https://www.nasdaq.com/press-release/cobra-acquisitions-llc-announces-settlement-agreement-prepa-2024-07-22">announcing a settlement agreement</a>.</li>



<li>ENGlobal (NASDAQ:<a href="https://investorplace.com/stock-quotes/eng-stock-quote/">ENG</a>) shares are gaining more than 22% without any clear news.</li>



<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is jumping over 20% with no news to report.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are climbing more than 19% despite a lack of news on Tuesday.</li>



<li>SCYNEXIS (NASDAQ:<a href="https://investorplace.com/stock-quotes/scyx-stock-quote/">SCYX</a>) stock is getting an over 15% boost on a <a href="https://www.nasdaq.com/press-release/scynexis-receive-10-million-milestone-payment-gsk-triggered-delivery-completed-furi">$10 million milestone payment</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) shares are up more than 13% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is crashing more than 59% after <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">pricing a public offering</a>.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are plummeting close to 31% <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">after a massive rally yesterday</a>.</li>



<li>Brera (NASDAQ:<a href="https://investorplace.com/stock-quotes/brea-stock-quote/">BREA</a>) stock is diving nearly 25% with strong pre-market trading this morning.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) shares are tumbling over 22% <a href="https://www.benzinga.com/news/24/07/39892411/caremax-shares-are-up-by-more-than-200-what-you-need-to-know">after a rally yesterday</a>.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) stock is taking a more than 19% beating after a recent rally.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are sliding over 19% <a href="https://investorplace.com/2024/07/why-is-castellum-ctm-stock-moving-today/">alongside volatility yesterday</a>.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is falling almost 16% as shares <a href="https://investorplace.com/2024/07/why-is-exicure-xcur-stock-down-27-today/">continue to come off a recent rally</a>.</li>



<li>Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) shares are dropping more than 15% today.</li>



<li>Polaris (NYSE:<a href="https://investorplace.com/stock-quotes/pii-stock-quote/">PII</a>) stock is slipping over 15% after <a href="https://www.marketwatch.com/story/polaris-stock-tumbles-11-after-earnings-fall-far-short-of-consensus-and-company-cuts-full-year-outlook-c3299335">missing earnings estimates</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares close out our pre-market stock movers down more than 14%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

An update from Nukkleus (NUKK) is now available. Emil Assentato has stepped down as CEO and board member of Nukkleus Inc., with Jamie Khurshid taki...

Nukkleus Appoints Jamie Khurshid as New CEO

Nukkleus ( ($NUKK) ) just unveiled an announcement. In a significant corporate reshuffle, a company issued a note that will mature in September 202...

Nukkleus Announces Leadership Changes and Strategic Reorganization

Nukkleus to implement 1-for-8 reverse stock split

Nukkleus (NUKK) announced that it will effect a 1-for-8 reverse split of the issued shares of its common stock, effective on October 24, 2024. The ...

Nukkleus announces 1-for-8 reverse stock split

19:50 EDT Nukkleus (NUKK) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...

Nukkleus Inc trading halted, news pending

The latest announcement is out from Nukkleus ( ($NUKK) ). On November 8, 2024, a company finalized several strategic agreements, including the sale...

Nukkleus Strengthens Position Amid Strategic Changes and Challenges

Nukkleus (NUKK) announced that it has successfully acquired a 51% controlling stake in Star 26 Capital, a defense acquisition company holding 95% o...

Nukkleus acquires 51% controlling stake in Star 26 Capital

Nukkleus stock is rocketing higher today as investors pile into the stock following news it acquired a majority stake in defense company Star 26 Ca...

Nukkleus Stock Rockets Higher Alongside Majority Star 26 Capital Stake

APDN

BACK

BREA

CMAX

CONN

CSSE

CSSEN

CSSEP

DTSS

FEIM

GNLN

IPDN

MIRA

NCPL

NMHI

OPTT

PRST

QNRX

RDZN

RNAZ

SCYX

SNTI

SOAR

TUSK

USEG

VSME

WHLR

WRNT

ZAPP

Press Releases

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

Small Cap

Opinion

Thinking about buying stock in Petros Pharmaceuticals, Xpeng Inc, Nukkleus, Cellectar Biosciences, or bluebird bio?

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets

Goldman Sachs Acquires Stake in Fintech Trailblazer Nukkleus According to a Recent SEC Filing

Nukkleus Signs Term Sheet for Acquisition of Leading Cross Border Payments Firm Mercury Global

Thinking about buying stock in BigBear.ai, Nukkleus, Singularity Future Technology, Regulus Therapeutics, or ATRenew?

Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024

Fintech

Nukkleus, Inc. Achieves Strategic Milestone with Acquisition of a Controlling Stake in Star 26 a Defense-focus acquisition company and a provider of Israel's Iron Dome Missile Defense System

Comments

Nukkleus

Nukkleus (NUKK) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌